Preliminary dose-response experiments. by Noelia Torremadé (3687523)

Subjects:

25OHD₃ increases expression of TRPV6 and Calbindin-D9k in duodenum of CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

Subjects:

25OHD₃ does not induce vascular calcification in CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

Subjects:

25OHD₃ restores calcium and PTH levels in CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

Subjects:

The effect of 25OHD3 on the expression of renal PMCA1b and NCX1 in CYP27B1^+/+ and CYP27B1^-/- mice. by Noelia Torremadé (3687523)

Subjects:

25OHD₃ increases expression of CalbindinD-28K in the kidneys of CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

Subjects:

VMH Menin knockdown induced decreased hippocampal D-serine levels and impaired synaptic functions. by Lige Leng (14803241)

RBC ROS production induces Band 3 phosphorylation, decreasing membrane deformability and lipid mobility. by Joseph Khoory (844565)

Subjects:

Klf5 and eIF5a suppress Ang II–induced expression of NOX1 in VSMCs. by Dong Ma (584680)

Subjects:

Recapitulation of Tumor Heterogeneity and Molecular Signatures in a 3D Brain Cancer Model with Decreased Sensitivity to Histone Deacetylase Inhibition by Stuart J. Smith (111275)

<i>upd2</i> down-regulation decreases sleep intensity. by Deniz Ertekin (9199661)

GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

“…Treatment with GSK343 resulted in significantly decreased migration. (D) After 24 hours of treatment with increasing concentrations of GSK343 (0, 5, 10 μM), COA3 and COA6 cells (4.0 × 10⁴) were plated in Transwell^® inserts and allowed to invade for 1 week through a Matrigel^™ layer. …”

Activation of ERα with estrogen simultaneously increases PR expression and decreases Myc expression in endometrial cancer cells. by Tamar Kavlashvili (849072)

The mutation D2267N within the G3 domain decreases the complement activation capacity. by Camilla Melin Fürst (402462)

SAUR63 interactions with PP2C.D proteins. by Punita Nagpal (185838)

Subjects:

Corticosterone treatment decreases MMP-2 promoter activity. by Eric A. Shikatani (131260)

“…MMP-2 mRNA levels were decreased with corticosterone treatment (A) (p = 0.006, n = 5). …”

Inner medullary expression of AQP2 and p-AQP2. by Sophie Constantin Lütken (689916)

Subjects:

pGab1 levels decreased over time in HCV-infected Huh7.5.1 cells. by Da-eun Nam (18927946)

Beta-catenin signaling is decreased in intermediate progenitor cells. by Christopher A. Mutch (243132)

“…<p>(<b>A</b>) Cortex from E14.5 Axin2-d2EGFP transgenic mice stained for GFP (green), Tbr2 (red), and DNA (blue). …”

Inhibition of F/P tyrosine kinase by imatinib in CEL patients decreased phosphorylation of JAK2, Stat3 and Stat5 in a time-dependent manner. by Bin Li (39349)